An in vivo study showed that butein could ameliorate the IDD process in diabetic rats, while Sirt1 was increased and acetyl-p53 was decreased in NP tissues in butein-treated rats. This evidence concerns the gene SIRT1 and intervertebral disk degenerative disorder.